Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $1.8 million.

  • Cardio Diagnostics Holdings' Shares Outstanding (Weighted Average) rose 11575.63% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 11575.63%. This contributed to the annual value of $26.9 million for FY2024, which is 11200.18% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $1.8 million for Q3 2025, which was up 11575.63% from $1.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Shares Outstanding (Weighted Average) high stood at $26.9 million for Q4 2024, and its period low was $702574.0 during Q1 2024.
  • Over the past 5 years, Cardio Diagnostics Holdings' median Shares Outstanding (Weighted Average) value was $3.7 million (recorded in 2022), while the average stood at $6.2 million.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Shares Outstanding (Weighted Average) surged by 31083.02% in 2023 and then plummeted by 9315.54% in 2024.
  • Cardio Diagnostics Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $1.2 million in 2021, then surged by 165.44% to $3.1 million in 2022, then skyrocketed by 310.83% to $12.7 million in 2023, then soared by 112.0% to $26.9 million in 2024, then crashed by 93.46% to $1.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $1.8 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.7 million in Q1 2025.